Emergent Biosolutions
EBS
EBS
199 hedge funds and large institutions have $907M invested in Emergent Biosolutions in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 73 increasing their positions, 68 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
199
Holders Change
+15
Holders Change %
+8.15%
% of All Funds
5.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
73
Reduced
68
Closed
11
Calls
$658K
Puts
$654K
Net Calls
+$4K
Net Calls Change
-$260K
Top Buyers
Top Sellers
| 1 |
1
Bank of New York Mellon
New York
|
$67.6M |
| 2 |
BC
2
Broadfin Capital
New York
|
$46.2M |
| 3 |
GC
3
Guggenheim Capital
Chicago,
Illinois
|
$14.1M |
| 4 |
4
Goldman Sachs
New York
|
$7.09M |
| 5 |
BIT
5
BlackRock Institutional Trust
San Francisco,
California
|
$23.4M |
